These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38292061)

  • 1. SIM2: Its Prognostic Significance and Oncogenic Role in Endometrial Carcinoma.
    Wei Y; Zhao X; Tang H; Ma J; Wang Y; Li L
    Onco Targets Ther; 2024; 17():45-61. PubMed ID: 38292061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-minded homolog 2 as a potential prognostic signature and assessment of its correlation with immune cell infiltration in pancreatic cancer.
    Hu Q; Wen N; Li F; Yang D; Yue C; Wu Z; Li M; Lu H
    Pol J Pathol; 2023; 74(4):232-247. PubMed ID: 38477085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZBTB7A, a potential biomarker for prognosis and immune infiltrates, inhibits progression of endometrial cancer based on bioinformatics analysis and experiments.
    Geng R; Zheng Y; Zhou D; Li Q; Li R; Guo X
    Cancer Cell Int; 2020 Nov; 20(1):542. PubMed ID: 33292231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transducer and activator of transcription family is a prognostic marker associated with immune infiltration in endometrial cancer.
    Zhou XY; Dai HY; Zhang H; Zhu JL; Hu H
    J Clin Lab Anal; 2022 Apr; 36(4):e24315. PubMed ID: 35244291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a prognostic model of luteolin for endometrial carcinoma.
    Zhao J; Jiao W; Sui X; Zou J; Wang J; Lin Z
    Am J Transl Res; 2023; 15(3):2122-2139. PubMed ID: 37056832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dachsous cadherin related 1 (DCHS1) is a novel biomarker for immune infiltration and epithelial-mesenchymal transition in endometrial cancer via pan-cancer analysis.
    Meijuan C; Fang M; Qian W
    J Ovarian Res; 2024 Aug; 17(1):162. PubMed ID: 39123216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor mutation burden in connection with immune-related survival in uterine corpus endometrial carcinoma.
    Zhao L; Fu X; Han X; Yu Y; Ye Y; Gao J
    Cancer Cell Int; 2021 Jan; 21(1):80. PubMed ID: 33509222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma.
    Wang G; Fu J; Liu M; Zheng Q
    PLoS One; 2024; 19(1):e0277872. PubMed ID: 38232115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive analysis of CEBPA on prognosis and function in uterine corpus endometrial carcinoma.
    Wang J; Huang W; Chai S; Gan J; Zeng Y; Long P; Pang L
    Sci Rep; 2024 Oct; 14(1):23773. PubMed ID: 39390018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNF183 Is a Prognostic Biomarker and Correlates With Tumor Purity, Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.
    Geng R; Zheng Y; Zhao L; Huang X; Qiang R; Zhang R; Guo X; Li R
    Front Genet; 2020; 11():595733. PubMed ID: 33324448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma.
    Zhou C; Li C; Yan F; Zheng Y
    Cancer Cell Int; 2020 Nov; 20(1):541. PubMed ID: 33292199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma.
    Zhang Q; Luo Y; Zhang S; Huang Q; Liu G
    Sci Rep; 2024 Feb; 14(1):4257. PubMed ID: 38383747
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Zhao Q; Chen G; Yang X; Wang T; Yuan S; Meng Q
    Comb Chem High Throughput Screen; 2023; 26(2):330-338. PubMed ID: 35379118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of the ferroptosis-associated MGST1 gene in relation to poor outcome and maladjusted immune cell infiltration in uterine corpus endometrial carcinoma.
    Yan J; Ye G; Shao Y
    J Clin Lab Anal; 2022 Apr; 36(4):e24317. PubMed ID: 35218676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of N-7 methylguanine-related mRNA prognostic model in uterine corpus endometrial carcinoma based on multi-omics data and immune-related analysis.
    Zhao J; Zou J; Jiao W; Lin L; Wang J; Lin Z
    Sci Rep; 2022 Nov; 12(1):18813. PubMed ID: 36335189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of zinc finger DHHC-type containing 1 is associated with poor prognosis and cancer cell growth and metastasis in uterine corpus endometrial carcinoma.
    Jiang N; Li D; Han Y; Luo ZG; Liu LB
    Aging (Albany NY); 2024 Jun; 16(11):9784-9812. PubMed ID: 38848146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma.
    He K; Li J; Huang X; Zhao W; Wang K; Wang T; Chen J; Wang Z; Yi J; Zhao S; Zhao L
    Front Oncol; 2023; 13():1090779. PubMed ID: 36776306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets in Uterine Corpus Endometrial cancer.
    Lei P; Wang H; Yu L; Xu C; Sun H; Lyu Y; Li L; Zhang DL
    Int Immunopharmacol; 2022 Jul; 108():108743. PubMed ID: 35413679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma.
    Zhang M; Liu Y; Hou S; Wang Y; Wang C; Yin Y; Chen X
    Mol Omics; 2022 Jul; 18(6):506-519. PubMed ID: 35485290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.